|1.||Hurley, Laurence H: 4 articles (01/2005 - 06/2002)|
|2.||Langova, Katerina: 2 articles (01/2015 - 06/2014)|
|3.||Kolarova, Hana: 2 articles (01/2015 - 06/2014)|
|4.||Bajgar, Robert: 2 articles (01/2015 - 06/2014)|
|5.||Akiyama, Masaharu: 2 articles (08/2009 - 09/2003)|
|6.||Davidson, K: 2 articles (09/2000 - 03/2000)|
|7.||Izbicka, E: 2 articles (09/2000 - 03/2000)|
|8.||Cai, Elizabeth: 1 article (01/2015)|
|9.||Fillerova, Regina: 1 article (01/2015)|
|10.||Fujiwara, Nana: 1 article (01/2015)|
01/01/2013 - "Efficacy of multiple low-dose photodynamic TMPYP4 therapy on cervical cancer tumour growth in nude mice."
01/01/2015 - "Conversely, both TMPyP and ClAlPcS2-PDT decreased C-MYC expression on non-tumor BJ cell line but not on tumor cell lines. "
01/01/2015 - "We revealed that both TMPyP and ClAlPcS2-PDT increased C-FOS expression on tumor cell lines (G361 and MCF7), but not on non-tumor BJ cell line. "
06/01/2013 - "The porphyrin-quinoxaline conjugate 8 displayed enhanced photocytotoxicity (IC50=0.06 μM) when compared to TMPyP against A549 cancer cells."
11/01/2009 - "We investigated 5,10,15,20-tetrakis (N-methyl-4-pyridyl)-21H,23H-porphyrin (TMPyP) as a potential cancer treatment. "
|4.||Photosensitivity Disorders (Photodermatitis)
01/01/2015 - "Together, these studies indicate that only low doses of TMPyP4, such as those typically used for photosensitization, are well tolerated in vivo. "
01/01/2015 - "Intraperitoneal administration of low TMPyP4 doses (10mg/kg), similar to those used for photosensitization, did not significantly reduce Th transcript levels in several catecholaminergic regions. "
11/01/2001 - "The nuclear transport pathways of the photosensitizers meso-tetra(4-sulfonatophenyl)porphyrin (TPPS4) and meso-tetra(4-N-methylpyridyl)porphyrin (TMPyP) during photosensitization and oxidative stress were characterized in CT-26 murine colon carcinoma cells using fluorescence microscopy and multi-pixel spectral imaging. "
10/18/2006 - "The wide applicability of the probe was demonstrated by detection of (1)O2 generated from a MoO(4)(2-)/H(2)O2 system, a photosensitization system of 5,10,15,20-tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-toluenesulfonate) (TMPyP), and a horseradish peroxidase catalyzed aerobic oxidation system of indole-3-acetic acid (IAA). "
|5.||Breast Neoplasms (Breast Cancer)
07/01/1999 - "The objectives of this study were (1) to set up a human breast cancer system that allows evaluation of the effects of telomerase inhibitors in cultured cells using a non-amplified telomerase assay and (2) to test this system using two drugs (cisplatin and TMPyP4) that affect the telomerase expression in breast cancer cells in culture. "
03/23/2010 - "The results showed that the apt-TMP complex exhibited a higher TMPyP4 accumulation in MCF7 breast cancer cells than in M10 normal epithelium cells. "
03/01/2000 - "Toxicity of the G-quadruplex interactive porphyrins (TMPyP4, TMPyP2) and azidothymidine (AZT) were tested using a cell-counting technique against normal human cell lines (CRL-2115 and CRL-2120, fibroblasts; NHEK-Ad, adult keratinocytes; CCL-241, small intestinal cells; NCM 460, colonic mucosal epithelial cells) and human tumor cell lines (MDA-MB 231 and Hs 578T, breast cancer; SK-N-FI, neuroblastoma; HeLa, cervix cancer; MIA PaCa-2, pancreatic cancer; HT-29 and HCT-116, colon cancer; DU 145, prostatic cancer cell line). "
|1.||Telomerase (Telomerase Reverse Transcriptase)
|3.||DNA (Deoxyribonucleic Acid)
|6.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|10.||Photosensitizing Agents (Photosensitizers)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Photochemotherapy (Photodynamic Therapy)